- Home
- MIST vs BHAV Comparison
MIST vs BHAV Comparison
Compare MIST & BHAV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$0.96
Company Overview
Basic Information| Metric | MIST | BHAV |
|---|---|---|
| Founded | 2003 | N/A |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 146.9M | 140.8M |
| IPO Year | 2019 | 2026 |
Fundamental Metrics
Financial Performance| Metric | MIST | BHAV |
|---|---|---|
| Price | $0.96 | $10.03 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $8.00 | N/A |
| AVG Volume (30 Days) | ★ 1.5M | 4.2K |
| Earning Date | 05-13-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $2,915.14 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.98 | $9.90 |
| 52 Week High | $3.06 | $10.05 |
Technical Indicators
Market Signals| Indicator | MIST | BHAV |
|---|---|---|
| Relative Strength Index (RSI) | 35.88 | 59.58 |
| Support Level | N/A | $9.98 |
| Resistance Level | $1.42 | $10.05 |
| Average True Range (ATR) | 0.07 | 0.00 |
| MACD | -0.01 | -0.00 |
| Stochastic Oscillator | 3.86 | 70.19 |
Price Performance
Historical Comparison MIST
BHAV
About MIST Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of cardiovascular medicines. Its approved product CARDAMYST (etripamil) nasal spray is available in the United States and is the self-administered treatment for use by patients anywhere, anytime an attack of PSVT occurs. It operates in single segment.
About BHAV BHAV Acquisition Corp Class A Ordinary Shares
BHAV Acquisition Corp is a blank check company.